Bridger Management, LLC Heron Therapeutics, Inc. Transaction History

Bridger Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$10.23 - $24.56 $17.6 Million - $42.3 Million	-1,721,816 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$17.42 - $26.61 $12.3 Million - $18.8 Million	-704,798 Reduced 29.04%	1,721,816 $40.5 Million
Q3 2019 Nov 14, 2019	SELL	$16.36 - $21.39 $6.87 Million - $8.98 Million	-419,941 Reduced 14.75%	2,426,614 $44.9 Million
Q2 2019 Aug 14, 2019	BUY	$16.93 - $26.22 $13.7 Million - $21.2 Million	810,356 Added 39.8%	2,846,555 $52.9 Million
Q1 2019 May 15, 2019	SELL	$23.15 - $28.34 $10.3 Million - $12.6 Million	-446,110 Reduced 17.97%	2,036,199 $49.8 Million
Q4 2018 Feb 14, 2019	BUY	$22.03 - $32.01 $4.24 Million - $6.15 Million	192,245 Added 8.39%	2,482,309 $64.4 Million
Q3 2018 Nov 14, 2018	BUY	$30.0 - $40.85 $8.77 Million - $11.9 Million	292,367 Added 14.64%	2,290,064 $72.5 Million
Q2 2018 Aug 14, 2018	BUY	$26.4 - $42.0 $19 Million - $30.2 Million	720,137 Added 56.37%	1,997,697 $77.6 Million
Q1 2018 May 15, 2018	BUY	$18.43 - $28.8 $23.5 Million - $36.8 Million	1,277,560 New	1,277,560 $35.3 Million

198

129M

94.7K

148K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $240M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Bridger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridger Management, LLC with notifications on news.